X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3847) 3847
Publication (390) 390
Newsletter (112) 112
Book Review (40) 40
Newspaper Article (21) 21
Book Chapter (17) 17
Conference Proceeding (17) 17
Magazine Article (12) 12
Transcript (10) 10
Dissertation (5) 5
Book / eBook (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2645) 2645
index medicus (2028) 2028
platelet-derived growth factor (1778) 1778
animals (1526) 1526
male (1244) 1244
female (999) 999
oncology (894) 894
imatinib mesylate (730) 730
middle aged (688) 688
mice (668) 668
antineoplastic agents - therapeutic use (658) 658
cancer (604) 604
adult (590) 590
growth factors (588) 588
expression (561) 561
pyrimidines - therapeutic use (553) 553
research (538) 538
benzamides (517) 517
aged (514) 514
piperazines - therapeutic use (511) 511
rats (459) 459
angiogenesis (456) 456
medicine (455) 455
research article (443) 443
vascular endothelial growth factor (423) 423
receptor, platelet-derived growth factor alpha - genetics (419) 419
gene expression (416) 416
tumors (409) 409
proteins (404) 404
kinases (402) 402
platelet-derived growth factor - metabolism (400) 400
care and treatment (378) 378
health aspects (377) 377
protein kinase inhibitors - therapeutic use (375) 375
multidisciplinary sciences (374) 374
signal transduction (372) 372
cell biology (360) 360
platelet-derived growth factor - therapeutic use (353) 353
treatment outcome (349) 349
science (347) 347
imatinib (345) 345
mutation (342) 342
analysis (336) 336
cells, cultured (335) 335
rodents (326) 326
cell proliferation (316) 316
growth-factor (314) 314
stem cells (308) 308
immunohistochemistry (293) 293
pharmacology & pharmacy (288) 288
cell proliferation - drug effects (286) 286
apoptosis (283) 283
hematology (280) 280
surgery (279) 279
proto-oncogene proteins c-sis (278) 278
cells (274) 274
physiological aspects (273) 273
platelet-derived growth factor - pharmacology (272) 272
medicine, research & experimental (259) 259
in-vitro (253) 253
disease models, animal (252) 252
proliferation (252) 252
article (250) 250
cell line, tumor (248) 248
proto-oncogene proteins c-kit - genetics (245) 245
genetic aspects (244) 244
therapy (244) 244
activation (243) 243
tyrosine (242) 242
metastasis (237) 237
fibroblasts (233) 233
receptors, platelet-derived growth factor - antagonists & inhibitors (232) 232
signal transduction - drug effects (232) 232
biology (230) 230
fibrosis (227) 227
phosphorylation (227) 227
smooth muscle (222) 222
wound healing (221) 221
inhibition (218) 218
receptor, platelet-derived growth factor alpha - metabolism (217) 217
medical research (216) 216
receptor, platelet-derived growth factor beta - metabolism (216) 216
endothelial growth-factor (210) 210
tyrosine kinase inhibitor (208) 208
pdgf (207) 207
studies (207) 207
cytokines (205) 205
antineoplastic agents - pharmacology (203) 203
inflammation (199) 199
pathology (197) 197
biochemistry & molecular biology (195) 195
chemotherapy (194) 194
prognosis (193) 193
in-vivo (187) 187
receptors, platelet-derived growth factor - metabolism (187) 187
gastrointestinal stromal tumors - genetics (186) 186
rats, sprague-dawley (185) 185
growth (184) 184
development and progression (183) 183
gastrointestinal stromal tumors - drug therapy (182) 182
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3876) 3876
German (30) 30
Chinese (27) 27
French (24) 24
Japanese (21) 21
Italian (8) 8
Spanish (8) 8
Dutch (6) 6
Hungarian (5) 5
Polish (5) 5
Russian (4) 4
Bulgarian (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Orthopaedics and Related Research, ISSN 0009-921X, 10/2011, Volume 469, Issue 10, pp. 2706 - 2715
Full-thickness chondral defects and early osteoarthritis continue to present major challenges for the patient and the orthopaedic surgeon as a result of the... 
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Surgery | Orthopedics | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | ENDOGENOUS OSTEOGENIC PROTEIN-1 | TGF-BETA | AUTOLOGOUS CONDITIONED SERUM | BONE-MARROW | TRANSFORMING GROWTH-FACTOR-BETA-1 | HUMAN ARTICULAR CHONDROCYTES | FACTOR-I | EQUINE MODEL | ORTHOPEDICS | MESENCHYMAL STEM-CELLS | INDUCED OSTEOARTHRITIS | Platelet-Derived Growth Factor - therapeutic use | Chondrogenesis - drug effects | Humans | Cartilage Diseases - drug therapy | Cartilage Diseases - pathology | Cartilage, Articular - pathology | Intercellular Signaling Peptides and Proteins - metabolism | Regeneration - drug effects | Animals | Transforming Growth Factors - therapeutic use | Cartilage, Articular - metabolism | Bone Morphogenetic Proteins - therapeutic use | Intercellular Signaling Peptides and Proteins - therapeutic use | Cartilage, Articular - drug effects | Drug Therapy, Combination | Insulin-Like Growth Factor I - therapeutic use | Cartilage Diseases - metabolism | Fibroblast Growth Factors - therapeutic use | Osteoarthritis | Fibroblast growth factors | Platelet-derived growth factor | Fibroblast growth factor | Cartilage (articular) | Transforming growth factor- beta | Regeneration | Molecular modelling | Reviews | Chondrocytes | Bone marrow | Extracellular matrix | Microenvironments | Injuries | Cartilage diseases | Clinically Relevant Strategies for Treating Cartilage and Meniscal Pathology | Symposium
Journal Article
Journal of Periodontology, ISSN 0022-3492, 08/2013, Volume 84, Issue 8, pp. 1180 - 1190
Background: Alveolar bone loss can be a major clinical concern affecting both functionality and esthetics. Osteoblasts are the main cells charged with the... 
intercellular signaling peptides and proteins | osteoblasts | Blood platelets | platelet‐rich plasma | regeneration | bone and bones | Regeneration | Intercellular signaling peptides and proteins | Bone and bones | Osteoblasts | Platelet-rich plasma | STEM-CELLS | DENTAL IMPLANTS | CHEMOTACTIC MIGRATION | MECHANISMS | MEDICINE | platelet-rich plasma | RESPONSES | IN-VITRO | PLATELETS | DENTISTRY, ORAL SURGERY & MEDICINE | MORPHOGENETIC PROTEIN-2 | FIBRIN MATRICES | Hepatocyte Growth Factor - therapeutic use | Intercellular Signaling Peptides and Proteins - analysis | Plasma | Platelet-Derived Growth Factor - therapeutic use | Proto-Oncogene Proteins c-sis - analysis | Humans | Middle Aged | Alveolar Process - drug effects | Male | Autocrine Communication - drug effects | Endothelial Growth Factors - analysis | Alveolar Process - cytology | Osteocalcin - therapeutic use | Platelet-Derived Growth Factor - analysis | Aged, 80 and over | Alkaline Phosphatase - analysis | Adult | Female | Cell Culture Techniques | Endothelial Growth Factors - therapeutic use | Transforming Growth Factor beta1 - analysis | Insulin-Like Growth Factor I - therapeutic use | Osteocalcin - analysis | Bone Regeneration - drug effects | Hepatocyte Growth Factor - analysis | Osteoblasts - drug effects | Vascular Endothelial Growth Factor A - therapeutic use | Cells, Cultured | Vascular Endothelial Growth Factor A - analysis | Chemotaxis - drug effects | Insulin-Like Growth Factor I - analysis | Cell Movement - drug effects | Transforming Growth Factor beta1 - therapeutic use | Proto-Oncogene Proteins c-sis - therapeutic use | Platelet-Rich Plasma | Aged | Cell Proliferation - drug effects | Collagen Type I - analysis | Intercellular Signaling Peptides and Proteins - therapeutic use | Collagen Type I - therapeutic use
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2017, Volume 23, Issue 5, pp. 1137 - 1148
Following the approval of bevacizumab, an antibody targeting VEGF-A, for advanced non-squamous non-small cell lung cancer (NSCLC) in 2006, intensive efforts... 
PHASE-III TRIAL | 1ST-LINE TREATMENT | VASCULOGENIC MIMICRY | ONCOLOGY-GROUP | ONCOLOGY | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | OVARIAN-CANCER | TUMOR ANGIOGENESIS | PLUS BEVACIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Non-Small-Cell Lung - pathology | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Risk Assessment | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - adverse effects | Neovascularization, Pathologic - epidemiology | Carcinoma, Non-Small-Cell Lung - epidemiology | Antibodies, Monoclonal - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neovascularization, Pathologic - pathology | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Indoles - adverse effects | Neovascularization, Pathologic - drug therapy | Angiogenesis Inhibitors - therapeutic use | Pyrroles - adverse effects | Indoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Pyrroles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Adenocarcinoma | Fibroblast growth factor | Platelet-derived growth factor | p53 Protein | Lung cancer | Clinical trials | Neuropilin | Non-small cell lung carcinoma | Bleeding | Bevacizumab | Vascular endothelial growth factor receptors | Genetic variance | Signaling | Lungs | Antiangiogenics | Isoforms | Antiangiogenic agents | Biomarkers | Bioindicators | Mutation | Vascular endothelial growth factor | Growth factors | Tumors | Cancer
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2015, Volume 21, Issue 15, pp. 1967 - 1978
Journal Article
Journal of Periodontology, ISSN 0022-3492, 12/2005, Volume 76, Issue 12, pp. 2205 - 2215
Journal Article
International Journal of Oral and Maxillofacial Implants, ISSN 0882-2786, 2003, Volume 18, Issue 1, pp. 93 - 103
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 02/2011, Volume 38, Issue 2, pp. 163 - 172
Journal Article
Journal Article
Journal of Periodontology, ISSN 0022-3492, 04/2013, Volume 84, Issue 4, pp. 456 - 464
Journal Article